During the assembly of Fig. 1b of this Letter, the sequences of the targeted regions in Eml4 and Alk, shown in the schematic in the top panel, were inadvertently swapped. In addition, the legend for the top panel of Fig. 1b should have read: “b, A schematic of the loci before and after the inversion with the location of the primers used (top panel). The sequences recognised by the guide RNAs are shown in italics, the protospacer adjacent motif (PAM) sequences are in bold and underlined. Asterisks indicate the predicted Cas9 cleavage sites (positions −3 and −4 from the PAM).”. The corrected panel is shown in Fig. 1 of this Corrigendum. We apologize for the confusion this may have caused.
This is the corrected top panel of Fig. 1b of the original Letter.
Additional information
The online version of the original article can be found at 10.1038/nature13902
PowerPoint slides
Rights and permissions
About this article
Cite this article
Maddalo, D., Manchado, E., Concepcion, C. et al. Correction: Corrigendum: In vivo engineering of oncogenic chromosomal rearrangements with the CRISPR/Cas9 system. Nature 524, 502 (2015). https://doi.org/10.1038/nature14571
Published:
Issue Date:
DOI: https://doi.org/10.1038/nature14571
This article is cited by
-
Artificial intelligence for precision medicine in neurodevelopmental disorders
npj Digital Medicine (2019)
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.
